Ken‐ichi Naruo

1.4k total citations
15 papers, 978 citations indexed

About

Ken‐ichi Naruo is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Ken‐ichi Naruo has authored 15 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Organic Chemistry. Recurrent topics in Ken‐ichi Naruo's work include Immune Cell Function and Interaction (4 papers), Immune Response and Inflammation (4 papers) and Immunotherapy and Immune Responses (4 papers). Ken‐ichi Naruo is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immune Response and Inflammation (4 papers) and Immunotherapy and Immune Responses (4 papers). Ken‐ichi Naruo collaborates with scholars based in Japan. Ken‐ichi Naruo's co-authors include Tsutomu Kurokawa, Tatsuya Kondo, Masaaki Miyamoto, K. Tsukamoto, Shuji Hinuma, Osamu Shiho, Yasuyoshi Arikawa, Shigenori Ohkawa, Masaru Koyama and Hiroyuki Kimura and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Ken‐ichi Naruo

15 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken‐ichi Naruo Japan 11 709 228 162 143 104 15 978
Dawn M. Bryce Canada 11 601 0.8× 139 0.6× 83 0.5× 75 0.5× 119 1.1× 15 792
Veli-Pekka Lehto Finland 10 457 0.6× 232 1.0× 79 0.5× 40 0.3× 68 0.7× 13 722
Vigdis Sørensen Norway 18 741 1.0× 294 1.3× 107 0.7× 67 0.5× 67 0.6× 28 991
Nathalie F. Worth Australia 11 936 1.3× 238 1.0× 96 0.6× 71 0.5× 55 0.5× 11 1.2k
Dick J. Schol Netherlands 11 473 0.7× 94 0.4× 152 0.9× 67 0.5× 218 2.1× 13 734
Keiko Mayne Australia 12 590 0.8× 397 1.7× 59 0.4× 41 0.3× 96 0.9× 17 849
Cecilia Annerén Sweden 17 786 1.1× 249 1.1× 129 0.8× 124 0.9× 186 1.8× 28 1.1k
Assou El‐Battari France 13 436 0.6× 138 0.6× 146 0.9× 29 0.2× 50 0.5× 20 572
Vinod Asundi United States 16 463 0.7× 391 1.7× 89 0.5× 115 0.8× 72 0.7× 20 717
Xun Shang United States 15 562 0.8× 282 1.2× 124 0.8× 70 0.5× 99 1.0× 23 908

Countries citing papers authored by Ken‐ichi Naruo

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichi Naruo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Naruo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Naruo more than expected).

Fields of papers citing papers by Ken‐ichi Naruo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Naruo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Naruo. The network helps show where Ken‐ichi Naruo may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Naruo

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Naruo. A scholar is included among the top collaborators of Ken‐ichi Naruo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Naruo. Ken‐ichi Naruo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Arikawa, Yasuyoshi, et al.. (2005). Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1,3-thiazole Derivatives as p38 MAP Kinase Inhibitors. Chemical and Pharmaceutical Bulletin. 53(4). 410–418. 20 indexed citations
2.
Arikawa, Yasuyoshi, Maki Miyamoto, Ken‐ichi Naruo, et al.. (2005). Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug:  Discovery of N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent. Journal of Medicinal Chemistry. 48(19). 5966–5979. 124 indexed citations
3.
Naruo, Ken‐ichi, et al.. (1995). Stimulation of Thrombopoiesis in Mice by Fibroblast Growth Factor 9. Growth Factors. 12(3). 179–190. 11 indexed citations
4.
Naruo, Ken‐ichi, et al.. (1993). Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties.. Journal of Biological Chemistry. 268(4). 2857–2864. 83 indexed citations
5.
Miyamoto, Masaaki, et al.. (1993). Molecular Cloning of a Novel Cytokine cDNA Encoding the Ninth Member of the Fibroblast Growth Factor Family, which has a Unique Secretion Property. Molecular and Cellular Biology. 13(7). 4251–4259. 339 indexed citations
6.
Naruo, Ken‐ichi, et al.. (1993). Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property.. Molecular and Cellular Biology. 13(7). 4251–4259. 243 indexed citations
7.
Saijo, Taketoshi & Ken‐ichi Naruo. (1989). Mechanism of induction of fever by TGP-3 (recombinant human interleukin 2). Possible involvement of interleukin 1.BETA..:— possible involvement of interleukin 1β —. Ensho. 9(5). 391–395. 1 indexed citations
8.
Naruo, Ken‐ichi, et al.. (1989). Detection and characterization of anti-tumour effector cells in Meth-A-bearing mice treated with recombinant human interleukin 2.. PubMed. 76(2). 278–83. 3 indexed citations
9.
Hinuma, Shuji, Ken‐ichi Naruo, Osamu Shiho, & K. Tsukamoto. (1989). Characteristics of Mouse Lymphoid Cells Proliferating in vitro by Recombinant Human Interleukin 2 (TGP‐3): Comparison between Normal and Nude Mice. Microbiology and Immunology. 33(9). 761–773. 2 indexed citations
10.
Hinuma, Shuji, et al.. (1987). Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.. PubMed. 60(2). 173–9. 19 indexed citations
11.
Hinuma, Shuji, Ken‐ichi Naruo, Osamu Shiho, & K. Tsukamoto. (1986). Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.. PubMed. 59(2). 251–9. 33 indexed citations
12.
Naruo, Ken‐ichi, Shuji Hinuma, Koichi Kato, et al.. (1985). Comparison of the biological properties of purified natural and recombinant human interleukin-2. Biochemical and Biophysical Research Communications. 128(1). 257–264. 42 indexed citations
13.
Hinuma, Shuji, Ken‐ichi Naruo, K. Tsukamoto, Kazuo Sugamura, & Yorio Hinuma. (1985). Production of cytotoxic factor(s) in human T cell lines transformed by a human retrovirus. Biochemical and Biophysical Research Communications. 130(3). 1052–1058. 12 indexed citations
14.
Naruo, Ken‐ichi, Yuzo Ichimori, Masaru Koyama, & K. Tsukamoto. (1984). Correlation of Interferon Gamma Inducing Ability to Sugar Binding Specificities of Various Lectins. Journal of Interferon Research. 4(2). 235–241. 4 indexed citations
15.
Hinuma, Shuji, Haruo Onda, Ken‐ichi Naruo, et al.. (1982). Translation of interleukin 2 mRNA from human peripheral blood leukocytes in Xenopus oocytes. Biochemical and Biophysical Research Communications. 109(2). 363–369. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026